Wuhan Sequence-Based Recombinant Antigens Expressed in E. coli Elicit Antibodies Capable of Binding with Omicron S-Protein
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25169016 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ekaterina Evtushenko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Faculty of Biology, Lomonosov Moscow State University, Moscow 119234, Russia. Hauptthemen laut MEDLINE: SARS-CoV-2, Escherichia coli, Antibodies, Viral, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, R-Pharm.
Abstract (Originalsprache)
The development of cross-reactive vaccines is one of the central aims of modern vaccinology. Continuous mutation and the emergence of new SARS-CoV-2 variants and subvariants create the problem of universal coronavirus vaccine design. Previously, the authors devised three recombinant coronavirus antigens, which were based on the sequence collected in 2019 (the Wuhan variant) and produced in an E. coli bacterial expression system. The present work has shown, for the first time, that these recombinant antigens induce the production of antibodies that clearly interact with produced in CHO full-length S-protein of the Omicron variant. The immunogenicity of these recombinant antigens was studied in formulations with different adjuvants: Freund’s adjuvant, Al(OH)3 and an adjuvant based on spherical particles (SPs), which are structurally modified plant virus. All adjuvanted formulations effectively stimulated Omicron-specific IgG production in mice. These universal coronavirus antigens could be considered the main component for the further development of broad-spectrum coronavirus vaccines for the prevention of SARS-CoV-2 infection. The present work also provides evidence that the synthetic biology approach is a promising strategy for the development of highly cross-reactive vaccines. Moreover, it is important to note that the bacterial expression system might be appropriate for the production of antigenically active universal antigens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, Faculty of Biology, Lomonosov Moscow State University, Moscow 119234, Russia.
- R-Pharm, Moscow 119421, Russia.
ORCID-Profile: Ekaterina Evtushenko, Ekaterina Ryabchevskaya, Angelina Kovalenko, Marina Arkhipenko, Nikolai Nikitin, Olga Karpova
Förderung
- Russian Science Foundation
- R-Pharm
Zitieren
APA
Evtushenko, E., Ryabchevskaya, E., Kovalenko, A., Granovskiy, D., Arkhipenko, M., Vasiliev, Y., Nikitin, N., & Karpova, O. (2024). Wuhan Sequence-Based Recombinant Antigens Expressed in E. coli Elicit Antibodies Capable of Binding with Omicron S-Protein. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169016
Vancouver
Evtushenko E, Ryabchevskaya E, Kovalenko A, Granovskiy D, Arkhipenko M, Vasiliev Y, et al. Wuhan Sequence-Based Recombinant Antigens Expressed in E. coli Elicit Antibodies Capable of Binding with Omicron S-Protein. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169016
BibTeX
@article{Evtushenko2024,
author = {Evtushenko, Ekaterina and Ryabchevskaya, Ekaterina and Kovalenko, Angelina and Granovskiy, Dmitriy and Arkhipenko, Marina and Vasiliev, Yuri and Nikitin, Nikolai and Karpova, Olga},
title = {Wuhan Sequence-Based Recombinant Antigens Expressed in E. coli Elicit Antibodies Capable of Binding with Omicron S-Protein},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25169016}
}
EUVIMED